Get App
Last Updated : May 08, 2020 11:25 AM IST | Source: Moneycontrol.com

Buy SBI Life Insurance Company; target of Rs 880: Prabhudas Lilladher

Prabhudas Lilladher is bullish on SBI Life Insurance Company has recommended buy rating on the stock with a target price of Rs 880 in its research report dated May 06, 2020.

Broker Research @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher's research report on SBI Life Insurance Company


SBI Life's NBP growth weakened to 20% YoY while seeing a tepid APE growth of 11% in FY20 and targets single digit growth for FY21. Though Protection biz growth moderated to 27% YoY it still continues to be the core focus while ULIPs performed better than peers. Margins continued to improve with 100bps YoY ending at 18.7% on back of favorable mix but were weaker than expected on conservative assumptions on future risks. Persistency continued to improve across all cohorts with ULIPs having largely stable experience, while NPar showed improvement.


Outlook


Overall operating metrics like persistency, margins, costs etc. expected to remain steady while growth is expected to slow down a bit going ahead. We retain BUY with revised TP of Rs 880 (from Rs 1,127) based on 2.4x (from 3.2x) Mar-22 P/EV.


For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.



Moneycontrol Ready Reckoner
Now that payment deadlines have been relaxed due to COVID-19, the Moneycontrol Ready Reckoner will help keep your date with insurance premiums, tax-saving investments and EMIs, among others.


Special Offer: Subscribe to Moneycontrol PRO’s annual plan for ₹1/- per day for the first year and claim exclusive benefits worth ₹20,000. Coupon code: PRO365

First Published on May 8, 2020 11:25 am
Sections
Follow us on